
Overview
Brainscan is a company that develops AI-powered diagnostic systems specifically for analyzing human brain CT scans. It has expanded its capabilities to detect 30 key brain pathologies and is working on a multimodal system for automated diagnosis support, which includes features like the analysis of contrast-enhanced CT scans. The company aims for FDA certification and U.S. patent approval by 2025 to enter the American medical market.
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 10 days early. All were audited by a statutory auditor.
- 202506/07/2026
- 202407/07/2025
- 202328/06/2024
- 202211/07/2023
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Stock quotes
- Open
- PLN 7.90
- High
- PLN 7.90
- Low
- PLN 7.90
- Volume
- 330
- Avg. vol.
- 58.2
- Market cap
- PLN 10.18M
- P/E ratio
- –
- EPS
- -PLN 3.34
- Shares outstanding
- 1.29M
- 52-week
- PLN 7.45 – 8.00
- Dividend yield
- –
- Dividend
- –
- Ex dividend date
- –
- ISIN
- PLBRNSN00016
- Exchange
- NewConnect
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 52.94k | USD -284.98k | USD -292.27k |
| Q1 2026 | USD 23.50k | USD -576.18k | USD -579.69k |
| Q4 2025 | USD 4.52k | USD -183.32k | USD -191.86k |
| Q3 2025 | USD 5.27k | USD -78.60k | USD -79.36k |
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Websites
- brainscan.aiHome – BrainScan.aiWordPress 7.1ElementorApache
Public procurement
2 tenders recorded as contractor, with a total value of $105,610.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Mar 3, 2026 | Development of digital services at Samodzielny Publiczny Zespół Opieki Zdrowotnej w Kędzierzynie-Koźlu to accelerate the digital transformation of healthcare | $68,266$68,266 | Samodzielny Publiczny Zespół Opieki Zdrowotnej | |
| Apr 23, 2024 | Supply of a system to support interpretation of head CT scans (36-month licence) | $37,344$37,344 | Samodzielny Publiczny Zespół Opieki Zdrowotnej w Leżajsku |
Brainscan has been a party to 3 cases before the National Appeal Chamber (since 2026).
| Date | Subject of dispute | Outcome | Other party | |
|---|---|---|---|---|
| Jul 15, 2026 | Rejection of the application for admission to the procedure | Dismissed | Centrum e-Zdrowia | |
| May 13, 2026 | Interest in obtaining a decision in favor of the party | Discontinued | Skarb Państwa - Centrum e-Zdrowia | |
| Jan 5, 2026 | Rejection of the application for admission to the procedure | Upheld | Skarb Państwa - Centrum e-Zdrowia |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2017-11-14.
26 1050 1230 1000 0090 8387 5600
92 1050 1230 1000 0090 8387 5188
44 1050 1230 1000 0090 8396 2382
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Nov 13, 2024 | Commercial Companies Code notice |
Public aid
20 public aid cases recorded, with a total value of $4,987,268.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 19, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $123$123 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Mar 3, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $226$226 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Feb 25, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $238$238 | Prezes Zakładu Ubezpieczeń Społecznych |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-09-01 | LUNGSCAN – System supporting the assessment of regression/progression of pathological changes visible in follow-up lung computed tomography scans during and after recovery from acute lung inflammation associated with SARS-CoV-2, based on artificial intelligence methods | $1.1M$1,099,272 | Operational Programme Smart Growth | |
| 2020-09-01 | Preparation of a project proposal for a Eurogrant planned under the EIC Accelerator programme | $71,814$71,814 | Operational Programme Smart Growth | |
| 2019-01-02 | BRAINSCAN – a system for the automated support of medical diagnostics, detection and localisation of potential pathological changes in head imaging examinations. | $751.4K$751,414 | Operational Programme Smart Growth |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Spinetime sp. z o.o. | $847,603.92 | spinetime.io | ||
| Surveily sp. z o.o. | $457,041.74 | surveily.com | ||
| Medmetrix sp. z o.o. | $382,348.34 | medmetrix.pl | ||
| Aiseemo sp. z o.o. | $367,508.51 | aiseemo.com | ||
| Affexy sp. z o.o. | $356,023.67 | affexy.com | ||
| IQ Med sp. z o.o. | $301,729.42 | iq-med.pl | ||
| Cosmoeye sp. z o.o. | $300,840.92 | cosmoeye.ai | ||
| Diagu sp. z o.o. | $220,756.70 | diagu.pl | ||
| Mo2s P.S.A. | $98,474.49 | mo2s.pl | ||
| Cephio sp. z o.o. | $50,121.04 | cephio.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-04-14 | Share capital increase (116,750.00 PLN → 119,920.00 PLN) | |
| 2023-07-24 | Share capital increase (100,750.00 PLN → 116,750.00 PLN) | |
| 2022-11-03 | Entered in the register |
FAQ
Last updated: 2026-07-09